Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.
作者信息
Soares C D, Mosqueda-Taylor A, de Carvalho M G F, de Almeida O P
机构信息
University of Campinas, Piracicaba, São Paulo, Brazil.
Laboratório de Citopatologia, Private Service, Natal, RN, Brazil.
出版信息
Br J Dermatol. 2021 Jan;184(1):e6. doi: 10.1111/bjd.19569. Epub 2020 Nov 2.
Abstract
摘要
相似文献
1
Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.口腔水疱性病变作为新型冠状病毒肺炎的早期体征：严重急性呼吸综合征冠状病毒2刺突蛋白的免疫组织化学检测
Br J Dermatol. 2021 Jan;184(1):e6. doi: 10.1111/bjd.19569. Epub 2020 Nov 2.
2
Eosinophilic pustular folliculitis with labial and oral involvement: report of a rare presentation.伴有唇部和口腔受累的嗜酸性脓疱性毛囊炎：罕见表现报告
Dermatol Online J. 2018 Oct 15;24(10):13030/qt1bj294tx.
3
The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.COVID-19 相关性坏疽性脓皮病和血栓性网状青斑的不同病理生理学：病例系列。
Br J Dermatol. 2021 Jan;184(1):141-150. doi: 10.1111/bjd.19415. Epub 2020 Sep 15.
4
A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection.一种用于快速血清学检测 SARS-CoV-2 感染的新型免疫荧光检测法。
Viruses. 2021 Apr 24;13(5):747. doi: 10.3390/v13050747.
5
Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.三种针对核衣壳蛋白或刺突蛋白的全自动抗SARS-CoV-2免疫测定的临床性能
J Med Virol. 2021 Apr;93(4):2262-2269. doi: 10.1002/jmv.26669. Epub 2020 Dec 1.
6
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.2020年8月在意大利首次检测到严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白N501突变。
Lancet Infect Dis. 2021 Jun;21(6):e147. doi: 10.1016/S1473-3099(21)00007-4. Epub 2021 Jan 12.
7
Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.抗 SARS-CoV-2 刺突 IgG 的异常糖基化是血小板的促血栓形成刺激物。
Blood. 2021 Oct 21;138(16):1481-1489. doi: 10.1182/blood.2021011871.
8
Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage.血管内皮生长因子（VEGF）和细胞外基质金属蛋白酶诱导因子（CD147）在不同伴有血栓性损伤的 SARS-CoV-2 阳性消化道中的相关性。
FASEB J. 2021 Dec;35(12):e21969. doi: 10.1096/fj.202100821RRR.
9
Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.胶体金免疫层析法快速检测严重急性呼吸综合征冠状病毒 2 刺突蛋白的研究进展。
Front Immunol. 2021 Mar 11;12:635677. doi: 10.3389/fimmu.2021.635677. eCollection 2021.
10
Production and application of polyclonal antibodies against SARS-CoV-2 viral spike protein. Development to rapid, highly sensitive diagnosis kit for early Corona viral detection among the population.抗SARS-CoV-2病毒刺突蛋白多克隆抗体的生产与应用。开发用于人群中冠状病毒早期检测的快速、高灵敏度诊断试剂盒。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10219-10221. doi: 10.26355/eurrev_202010_23244.
引用本文的文献
1
Oral Mucosal Manifestations Associated with PCR Positivity in Patients with COVID-19.新型冠状病毒肺炎患者PCR检测呈阳性相关的口腔黏膜表现
Dermatol Pract Concept. 2024 Jan 1;14(1):e2024045. doi: 10.5826/dpc.1401a45.
2
A reflection on COVID-19 and oral mucosal lesion: a systematic review.关于新冠病毒病与口腔黏膜病变的思考：一项系统综述
Front Oral Health. 2023 Dec 18;4:1322458. doi: 10.3389/froh.2023.1322458. eCollection 2023.
3
The Oral Lesion in the COVID-19 Patient: Is It True Oral Manifestation or Not?新冠病毒肺炎患者的口腔病变：是真正的口腔表现吗？
Infect Drug Resist. 2023 Jul 4;16:4357-4385. doi: 10.2147/IDR.S411615. eCollection 2023.
4
Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19.COVID-19 口腔表现的发病机制与多组学分析。
Front Immunol. 2022 Jul 4;13:879792. doi: 10.3389/fimmu.2022.879792. eCollection 2022.
5
SARS-CoV-2 in saliva, viremia and seroprevalence for COVID-19 surveillance at a single hematopoietic stem cell transplantation center: a prospective cohort study.在单个造血干细胞移植中心进行的 COVID-19 监测中的唾液、病毒血症和血清阳性率：一项前瞻性队列研究。
Rev Inst Med Trop Sao Paulo. 2022 Jun 6;64:e39. doi: 10.1590/S1678-9946202264039. eCollection 2022.
6
Oral mucosa lesions in confirmed and non-vaccinated cases for COVID-19: A systematic review.确诊和未接种疫苗的 COVID-19 病例中的口腔黏膜损伤：系统评价。
J Stomatol Oral Maxillofac Surg. 2022 Oct;123(5):e241-e250. doi: 10.1016/j.jormas.2022.05.005. Epub 2022 May 10.
7
Oral manifestations associated with COVID-19 disease: An observational cross sectional study.与2019冠状病毒病相关的口腔表现：一项观察性横断面研究。
J Oral Biol Craniofac Res. 2022 Mar-Apr;12(2):279-283. doi: 10.1016/j.jobcr.2022.03.008. Epub 2022 Mar 19.
8
Morphological and tissue-based molecular characterization of oral lesions in patients with COVID-19: A living systematic review.对 COVID-19 患者口腔病变的形态学和基于组织的分子特征进行描述：一项实时系统综述。
Arch Oral Biol. 2022 Apr;136:105374. doi: 10.1016/j.archoralbio.2022.105374. Epub 2022 Feb 12.
9
COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.新型冠状病毒肺炎患者口腔黏膜病变：系统评价。
Int J Dermatol. 2022 Jan;61(1):20-32. doi: 10.1111/ijd.15889. Epub 2021 Sep 22.
10
[Oral Findings in Patients With COVID-19].[新型冠状病毒肺炎患者的口腔检查结果]
Actas Dermosifiliogr. 2022 Feb;113(2):183-186. doi: 10.1016/j.ad.2021.08.007. Epub 2021 Sep 16.
本文引用的文献
1
Letter to Editor: Oral lesions in a patient with Covid-19.致编辑的信：一名新冠肺炎患者的口腔病变
Med Oral Patol Oral Cir Bucal. 2020 Jul 1;25(4):e563-e564. doi: 10.4317/medoral.24044.
2
Oral vesiculobullous lesions associated with SARS-CoV-2 infection.与严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）感染相关的口腔水疱性病变
Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):710-712. doi: 10.1111/odi.13382. Epub 2020 May 29.
Zotero 插件